3
2
1

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

2026/07/22

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

2026/04/24

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

2026/03/04

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

2026/02/02

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

2026/01/19

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

2026/01/04

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

2025-12-19

Scientists Crack the "Xenogeneic Barrier", Offering a New Path for Growing Human Organs in Animals​

For a long time, human cells have often been excluded and struggled to survive in animal embryos due to the "xenogeneic barrier." The mainstream strategy in the past involved genetically engineering human cells to enhance their anti-apoptotic capabilities, but this approach carries potential safety risks such as carcinogenesis. How can this barrier be overcome more safely? A collaborative team led by the University of Texas Southwestern Medical Center and BGI Research used mice as a model to tackle this issue and achieved a critical breakthrough.

2025-12-12

No Need for Open-Chest Surgery: Stem Cell Patch Enables Minimally Invasive Heart Repair

Recently, a joint research team from the Mayo Clinic and the University of Nebraska Medical Center published a breakthrough study in the Journal of Biomedical Materials Research—they successfully developed a minimally implantable stem cell patch that can repair damaged hearts without open-chest surgery, providing a safer treatment option for heart failure patients. This achievement signifies the deep integration of regenerative medicine and minimally invasive interventional technology, which is expected to reshape the clinical approach to heart repair.

2025-12-12

Tsinghua University Team Makes New Progress in Cross-Scale Biological Sample Cryopreservation

Cryopreservation technology, as a key support for cell therapy, regenerative medicine, organ transplantation, and biological resource preservation, has long been constrained by ice crystal damage—from single cells to complex organs, the formation, propagation, and recrystallization of ice during rewarming progressively amplify structural and functional damage. Recently, Assistant Professor Geng Hongya’s team at Tsinghua Shenzhen International Graduate School has achieved a breakthrough in cross-scale biological sample cryopreservation. The related findings were published in the top international journal Advanced Materials, offering innovative solutions to two core challenges: low-temperature ice inhibition and efficient rewarming.

2025-11-28

Breaking Through the Bottleneck: New Technology Holds Promise for Solving the Problem of Frozen Organ Cracking

This research represents a solid step toward this long-term goal at the scientific and technological foundation level. With the continuous iteration of related technologies, organ banks, once confined to science fiction, may become a reality, bringing hope to millions of patients worldwide awaiting organ transplants.

2025-11-28

World's First 3D-Printed Immune-Compatible Material Opens New Avenues for Organ Transplants and Drug Delivery

A University of Virginia research team has pioneered a novel 3D-printable material compatible with the human immune system, as reported in the latest issue of Advanced Materials.

< 1...789...28 >